The guiding mission of the Centre for Inflammation Biology & Cancer Immunology (CIBCI) is to be an internationally renowned centre for research and training in inflammation biology and tumour immunobiology.
Our researchers aspire to advance the fundamental and applied knowledge of the biology, diagnosis and treatment of inflammation, its associated pathologies, and its bearing on tumour immunobiology. Our collective aim is to identify key mechanisms and pathways underlying inflammation and cancer and to create opportunities for novel treatments for human disease.
CIBCI’s interdisciplinary programme brings together academics, clinicians and trainees to work on clinically relevant cellular and molecular mechanisms of inflammation and tumour immunobiology. This creates a stimulating environment to develop, investigate and apply cutting-edge models and techniques, both experimental and computational, to advance the understanding of human inflammatory disease and cancer. Our projects include studies on tissue imaging, immune cell signalling, immunometabolism, wound healing, neuro-immune interactions, antigen processing and presentation, and innate and adaptive immune cell function, differentiation and regulation.
We foster a collaborative environment that stimulates interactions between all who work in inflammation biology and/or cancer immunology across the King’s faculty, with the aim to advance both research and education in these areas.